A detailed history of Agf Investments LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Agf Investments LLC holds 6,072 shares of VRTX stock, worth $3.05 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,072
Previous 3,528 72.11%
Holding current value
$3.05 Million
Previous $994,000 76.86%
% of portfolio
0.16%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $696,623 - $777,268
2,544 Added 72.11%
6,072 $1.76 Million
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $10,808 - $13,457
-46 Reduced 1.29%
3,528 $994,000
Q1 2022

May 10, 2022

SELL
$221.42 - $260.97 $717,622 - $845,803
-3,241 Reduced 47.56%
3,574 $933,000
Q4 2021

Feb 01, 2022

BUY
$177.01 - $223.45 $135,589 - $171,162
766 Added 12.66%
6,815 $1.5 Million
Q3 2021

Nov 10, 2021

BUY
$181.39 - $202.99 $169,781 - $189,998
936 Added 18.31%
6,049 $1.1 Million
Q2 2021

Aug 12, 2021

BUY
$187.49 - $221.1 $24,561 - $28,964
131 Added 2.63%
5,113 $1.03 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $350,484 - $408,537
-1,693 Reduced 25.36%
4,982 $1.07 Million
Q4 2020

Feb 08, 2021

SELL
$207.01 - $276.09 $82,389 - $109,883
-398 Reduced 5.63%
6,675 $1.58 Million
Q3 2020

Nov 12, 2020

SELL
$255.65 - $303.1 $538,654 - $638,631
-2,107 Reduced 22.95%
7,073 $1.93 Million
Q2 2020

Aug 11, 2020

BUY
$225.48 - $295.8 $826,158 - $1.08 Million
3,664 Added 66.42%
9,180 $2.67 Million
Q1 2020

May 08, 2020

SELL
$199.77 - $247.81 $303,250 - $376,175
-1,518 Reduced 21.58%
5,516 $1.31 Million
Q4 2019

Feb 12, 2020

SELL
$166.71 - $223.91 $395,602 - $531,338
-2,373 Reduced 25.23%
7,034 $1.54 Million
Q3 2019

Nov 12, 2019

SELL
$166.23 - $187.09 $21,942 - $24,695
-132 Reduced 1.38%
9,407 $1.59 Million
Q2 2019

Jul 30, 2019

BUY
$164.61 - $190.37 $948,318 - $1.1 Million
5,761 Added 152.49%
9,539 $1.75 Million
Q1 2019

May 13, 2019

BUY
$163.73 - $194.7 $491,353 - $584,294
3,001 Added 386.23%
3,778 $695,000
Q4 2018

Feb 08, 2019

BUY
$151.91 - $192.21 $5,316 - $6,727
35 Added 4.72%
777 $129,000
Q3 2018

Nov 07, 2018

SELL
$167.73 - $192.74 $148,441 - $170,574
-885 Reduced 54.39%
742 $143,000
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $237,086 - $276,524
1,627 New
1,627 $277,000
Q1 2018

May 04, 2018

SELL
$151.6 - $177.13 $20,617 - $24,089
-136 Closed
0 $0
Q4 2017

Feb 07, 2018

BUY
$137.28 - $155.55 $9,884 - $11,199
72 Added 112.5%
136 $21,000
Q3 2017

Nov 09, 2017

BUY
$148.13 - $162.24 $9,480 - $10,383
64
64 $10,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.